Abstract
In inflammatory bowel diseases (IBD), risk of thrombosis and production of antibodies are increased. In autoimmune and inflammatory disorders, a role of anti-prothrombin (aPT) antibodies in developing thrombosis has been hypothesised. The aim of the study is to evaluate the prevalence of aPT antibodies in IBD patients, with and without thrombosis.
Lingua originale | English |
---|---|
pagine (da-a) | 1281-1286 |
Numero di pagine | 6 |
Rivista | International Journal of Colorectal Disease |
Volume | 28 |
DOI | |
Stato di pubblicazione | Pubblicato - 2013 |
Keywords
- Thrombosis